37,871 Shares in CVS Health Corporation (NYSE:CVS) Purchased by China Universal Asset Management Co. Ltd.

China Universal Asset Management Co. Ltd. acquired a new stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 37,871 shares of the pharmacy operator's stock, valued at approximately $2,566,000.

Other large investors have also recently made changes to their positions in the company. Hopwood Financial Services Inc. acquired a new stake in CVS Health in the 4th quarter valued at about $29,000. McIlrath & Eck LLC raised its holdings in CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after acquiring an additional 174 shares during the last quarter. Sierra Ocean LLC raised its holdings in CVS Health by 584.8% in the 1st quarter. Sierra Ocean LLC now owns 719 shares of the pharmacy operator's stock valued at $49,000 after acquiring an additional 614 shares during the last quarter. MV Capital Management Inc. raised its holdings in CVS Health by 63.9% in the 1st quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator's stock valued at $50,000 after acquiring an additional 289 shares during the last quarter. Finally, Dunhill Financial LLC grew its stake in shares of CVS Health by 147.2% in the 1st quarter. Dunhill Financial LLC now owns 749 shares of the pharmacy operator's stock valued at $51,000 after buying an additional 446 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of CVS Health stock in a transaction dated Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the acquisition, the director owned 12,007 shares of the company's stock, valued at approximately $764,845.90. This represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.22% of the stock is currently owned by company insiders.

CVS Health Stock Down 0.4%

Shares of CVS stock traded down $0.29 on Wednesday, reaching $66.65. 6,329,968 shares of the stock were exchanged, compared to its average volume of 10,816,935. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The business's 50 day moving average price is $65.18 and its 200 day moving average price is $61.90. The company has a market capitalization of $84.31 billion, a price-to-earnings ratio of 15.91, a PEG ratio of 0.96 and a beta of 0.57. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The firm had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The company's revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.31 earnings per share. As a group, sell-side analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Tuesday, July 22nd will be given a $0.665 dividend. The ex-dividend date of this dividend is Tuesday, July 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.99%. CVS Health's dividend payout ratio (DPR) is presently 63.48%.

Analyst Ratings Changes

Several research firms have recently weighed in on CVS. Truist Financial increased their price target on shares of CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Jefferies Financial Group increased their price target on shares of CVS Health from $74.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Wall Street Zen raised shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Barclays set a $79.00 price objective on shares of CVS Health and gave the stock an "overweight" rating in a research report on Monday, June 2nd. Finally, Wells Fargo & Company reaffirmed an "overweight" rating and set a $84.00 price objective (up previously from $76.00) on shares of CVS Health in a research report on Tuesday, May 6th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $75.06.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.